MarginsXMarginsX
Home › Canada › TSX stocks › RVX

Resverlogix Corp. (TSX: RVX)

RVX trades on the Toronto Stock Exchange in Life Sciences, headquartered in Alberta. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$0.0800
0.00% on the day
Market cap (C$)
C$25.8M
TMX list, October 31, 2026
Market cap (US$)
US$18.1M
Nano cap at 1.4257 C$/US$
1-year return
-20.0%
-20.0% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for RVX.TO, last bar 2026-11-13, computed by MarginsX.

Profile

FieldValue
TickerRVX on the Toronto Stock Exchange
Yahoo symbolRVX.TO
SectorLife Sciences
HeadquartersAlberta
Listed2005-01-17
Listing typeTSXV Grad
Shares outstanding344,286,709
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIKNo SEC filer matched on exact name with a Canadian address or US interlisting
WebsiteNo company website on record

Returns

WindowReturn
1 day0.0%
1 week0.0%
1 month-11.1%
3 months-27.3%
6 months-20.0%
Year to date-20.0%
1 year-20.0%
From 52-week high-42.9%
52-week rangeC$0.0700 to C$0.1400

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

68 documents in 6 types. Each title links to the document at its source.

Annual financial statements (5)

DocumentTypeFiled
Financial Statement Q4 2025
Period Q4 2025
Annual financial statements2025-12-31
Financial Statement Q4 2024
Period Q4 2024
Annual financial statements2024-12-31
Financial Statement Q4 2023
Period Q4 2023
Annual financial statements2023-12-31
Financial Statement Q4 2022
Period Q4 2022
Annual financial statements2022-12-31

Interim financial statements (18)

DocumentTypeFiled
November 13, 2026 : Financial Statement Q3 2026
Period Q3 2026
Interim financial statements2026-11-13
Financial Statement Q2 2026
Period Q2 2026
Interim financial statements2026-06-30
Financial Statement Q1 2026
Period Q1 2026
Interim financial statements2026-03-31
Financial Statement Q3 2025
Period Q3 2025
Interim financial statements2025-09-30

MD&A (24)

DocumentTypeFiled
MD&A Q4 2025
Period Q4 2025
MD&A (annual)2025-12-31
MD&A Q4 2024
Period Q4 2024
MD&A (annual)2024-12-31
MD&A Q4 2023
Period Q4 2023
MD&A (annual)2023-12-31
MD&A Q4 2022
Period Q4 2022
MD&A (annual)2022-12-31

Annual information form (6)

DocumentTypeFiled
Annual Information Form 2025
Period Q4 2025
Annual information form2025-12-31
Annual Information Form 2024
Period Q4 2024
Annual information form2024-12-31
Annual Information Form 2023
Period Q4 2023
Annual information form2023-12-31
Annual Information Form 2022
Period Q4 2022
Annual information form2022-12-31

Management information circular / proxy (11)

DocumentTypeFiled
Annual Meeting of Shareholders - Notice of Meeting and Management Information Circular
Period Q2 2026
Management information circular2026-05-21
Annual Meeting of Shareholders - Notice of Meeting and Management Information Circular
Period Q1 2025
Management information circular2025-05-23
Annual Meeting of Shareholders - Notice of Meeting and Management Information Circular 2024
Period Q2 2024
Management information circular2024-07-10
Annual Meeting of Shareholders - Notice of Meeting and Management Information Circular
Period Q2 2023
Management information circular2023-05-16

Other (4)

DocumentTypeFiled
PresentationInvestor presentation2026-06-25
Fact Sheet
Period FY2024
Investor presentation2024-11-14
Financial StatementsFinancial statements (period not stated)2020-12-31
Annual and Special Meeting of Shareholders - Notice-and-Access NotificationOtherNo date

Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2011-12-01EquityUS$1.8MUS$1.8MSEC EDGAR
2011-06-21Equity, Option To AcquireUS$10.5MUS$10.5MSEC EDGAR

Source: SEC EDGAR Form D filings matched on exact issuer name. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
ROMJRubicon Organics Inc.TSXVC$25.8M-4.4%-20.4%
CHERCheelcare Inc.TSXVC$27.0M-3.0%+45.6%
PINKPerimeter Medical Imaging AI Inc.TSXVC$27.5M-31.8%-16.7%
LABSMediPharm Labs Corp.TSXC$27.8M-7.1%-7.1%
ZYUSZYUS Life Sciences CorporationTSXVC$29.8M-20.0%-42.9%

The app has the price chart, every filing, private raises and the full peer set for RVX.

Open in the app